Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | GPR160 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GPR160 mRNA | CTD | PMID:22079256 | 1,1-dichloroethene | decreases expression | EXP | | 6480464 | vinylidene chloride results in decreased expression of GPR160 mRNA | CTD | PMID:26682919 | 1,2-dimethylhydrazine | decreases expression | EXP | | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of GPR160 mRNA | CTD | PMID:22206623 | 17beta-estradiol | multiple interactions | ISO | GPR160 (Homo sapiens) | 6480464 | [Estradiol co-treated with TGFB1 protein] results in decreased expression of GPR160 mRNA | CTD | PMID:30165855 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | GPR160 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GPR160 mRNA | CTD | PMID:17101203 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of GPR160 mRNA | CTD | PMID:26377647 | 2-palmitoylglycerol | increases expression | ISO | GPR160 (Homo sapiens) | 6480464 | 2-palmitoylglycerol results in increased expression of GPR160 mRNA | CTD | PMID:37199045 | 4-hydroxyphenyl retinamide | decreases expression | EXP | | 6480464 | Fenretinide results in decreased expression of GPR160 mRNA | CTD | PMID:28973697 | 6-propyl-2-thiouracil | increases expression | ISO | Gpr160 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of GPR160 mRNA | CTD | PMID:25825206 | acetamide | increases expression | ISO | Gpr160 (Rattus norvegicus) | 6480464 | acetamide results in increased expression of GPR160 mRNA | CTD | PMID:31881176 | aflatoxin B1 | affects expression | ISO | GPR160 (Homo sapiens) | 6480464 | Aflatoxin B1 affects the expression of GPR160 protein | CTD | PMID:20106945 | aflatoxin B1 | decreases expression | ISO | GPR160 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of GPR160 mRNA | CTD | PMID:22100608 | all-trans-retinoic acid | increases expression | ISO | GPR160 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of GPR160 mRNA | CTD | PMID:23830798 and PMID:33167477 | aristolochic acid A | decreases expression | ISO | GPR160 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of GPR160 mRNA | CTD | PMID:33212167 | benzo[a]pyrene | decreases methylation | ISO | GPR160 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of GPR160 promoter | CTD | PMID:27901495 | benzo[a]pyrene | decreases expression | ISO | GPR160 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of GPR160 mRNA | CTD | PMID:32234424 | benzo[a]pyrene | affects methylation | ISO | GPR160 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of GPR160 5' UTR | CTD | PMID:27901495 | Benzo[k]fluoranthene | decreases expression | EXP | | 6480464 | benzo(k)fluoranthene results in decreased expression of GPR160 mRNA | CTD | PMID:26377693 | bisphenol A | decreases expression | ISO | Gpr160 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of GPR160 mRNA | CTD | PMID:25181051 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of GPR160 mRNA | CTD | PMID:32156529 | bisphenol A | decreases methylation | ISO | GPR160 (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of GPR160 gene | CTD | PMID:31601247 | bisphenol A | multiple interactions | ISO | GPR160 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of GPR160 gene | CTD | PMID:31601247 | bisphenol A | increases expression | ISO | Gpr160 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of GPR160 mRNA | CTD | PMID:30816183 and PMID:32528016 | bisphenol A | increases methylation | ISO | Gpr160 (Rattus norvegicus) | 6480464 | bisphenol A results in increased methylation of GPR160 gene | CTD | PMID:28505145 | butanal | increases expression | ISO | GPR160 (Homo sapiens) | 6480464 | butyraldehyde results in increased expression of GPR160 mRNA | CTD | PMID:26079696 | carbamazepine | affects expression | ISO | GPR160 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of GPR160 mRNA | CTD | PMID:25979313 | carbon nanotube | increases expression | EXP | | 6480464 | Nanotubes more ... | CTD | PMID:25554681 and PMID:25620056 | chlorpyrifos | increases expression | EXP | | 6480464 | Chlorpyrifos results in increased expression of GPR160 mRNA | CTD | PMID:34289071 | choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GPR160 mRNA | CTD | PMID:20938992 | chromium(6+) | affects expression | ISO | GPR160 (Homo sapiens) | 6480464 | chromium hexavalent ion affects the expression of GPR160 mRNA | CTD | PMID:30690063 | cisplatin | decreases expression | ISO | GPR160 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of GPR160 mRNA | CTD | PMID:27392435 | copper(II) sulfate | decreases expression | ISO | GPR160 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of GPR160 mRNA | CTD | PMID:19549813 | cordycepin | increases expression | EXP | | 6480464 | cordycepin results in increased expression of GPR160 mRNA | CTD | PMID:32042022 | coumestrol | decreases expression | ISO | GPR160 (Homo sapiens) | 6480464 | Coumestrol results in decreased expression of GPR160 mRNA | CTD | PMID:19167446 | cyclosporin A | decreases expression | ISO | GPR160 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of GPR160 mRNA | CTD | PMID:20106945 and PMID:25562108 | cyclosporin A | increases expression | ISO | GPR160 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of GPR160 mRNA | CTD | PMID:27989131 | dicrotophos | decreases expression | ISO | GPR160 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of GPR160 mRNA | CTD | PMID:28302478 | dioxygen | increases expression | ISO | GPR160 (Homo sapiens) | 6480464 | Oxygen deficiency results in increased expression of GPR160 mRNA | CTD | PMID:26516004 | dioxygen | multiple interactions | EXP | | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GPR160 mRNA | CTD | PMID:30529165 | dorsomorphin | multiple interactions | ISO | GPR160 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | endosulfan | increases expression | ISO | Gpr160 (Rattus norvegicus) | 6480464 | Endosulfan results in increased expression of GPR160 mRNA | CTD | PMID:29391264 | entinostat | multiple interactions | ISO | GPR160 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GPR160 mRNA | CTD | PMID:27188386 | entinostat | increases expression | ISO | GPR160 (Homo sapiens) | 6480464 | entinostat results in increased expression of GPR160 mRNA | CTD | PMID:26272509 | folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GPR160 mRNA | CTD | PMID:20938992 | fulvestrant | multiple interactions | ISO | GPR160 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of GPR160 gene | CTD | PMID:31601247 | glycidol | increases expression | ISO | Gpr160 (Rattus norvegicus) | 6480464 | glycidol results in increased expression of GPR160 mRNA | CTD | PMID:24915197 | isoprenaline | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of GPR160 mRNA | CTD | PMID:20003209 | L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GPR160 mRNA | CTD | PMID:20938992 | menadione | affects expression | ISO | GPR160 (Homo sapiens) | 6480464 | Vitamin K 3 affects the expression of GPR160 mRNA | CTD | PMID:20044591 | methyl methanesulfonate | decreases expression | ISO | GPR160 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in decreased expression of GPR160 mRNA | CTD | PMID:23649840 | methylmercury chloride | decreases expression | ISO | GPR160 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of GPR160 mRNA | CTD | PMID:28001369 | O-methyleugenol | decreases expression | ISO | GPR160 (Homo sapiens) | 6480464 | methyleugenol results in decreased expression of GPR160 mRNA | CTD | PMID:32234424 | ozone | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of GPR160 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of GPR160 mRNA | CTD | PMID:34911549 | pentanal | increases expression | ISO | GPR160 (Homo sapiens) | 6480464 | pentanal results in increased expression of GPR160 mRNA | CTD | PMID:26079696 | pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of GPR160 mRNA | CTD | PMID:19710929 | potassium chromate | multiple interactions | ISO | GPR160 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GPR160 mRNA | CTD | PMID:22079256 | potassium chromate | increases expression | ISO | GPR160 (Homo sapiens) | 6480464 | potassium chromate(VI) results in increased expression of GPR160 mRNA | CTD | PMID:22714537 | potassium chromate | decreases expression | ISO | GPR160 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of GPR160 mRNA | CTD | PMID:22079256 | propanal | increases expression | ISO | GPR160 (Homo sapiens) | 6480464 | propionaldehyde results in increased expression of GPR160 mRNA | CTD | PMID:26079696 | quercetin | decreases expression | ISO | GPR160 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of GPR160 mRNA | CTD | PMID:21632981 | SB 431542 | multiple interactions | ISO | GPR160 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | silicon dioxide | decreases expression | ISO | GPR160 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of GPR160 mRNA | CTD | PMID:25895662 | titanium dioxide | increases expression | EXP | | 6480464 | titanium dioxide results in increased expression of GPR160 mRNA | CTD | PMID:23409001 | trichloroethene | decreases expression | ISO | Gpr160 (Rattus norvegicus) | 6480464 | Trichloroethylene results in decreased expression of GPR160 mRNA | CTD | PMID:33387578 | trichostatin A | increases expression | ISO | GPR160 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of GPR160 mRNA | CTD | PMID:24935251 | triptonide | affects expression | EXP | | 6480464 | triptonide affects the expression of GPR160 mRNA | CTD | PMID:33045310 | troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of GPR160 mRNA | CTD | PMID:28973697 | trovafloxacin | decreases expression | EXP | | 6480464 | trovafloxacin results in decreased expression of GPR160 mRNA | CTD | PMID:35537566 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of GPR160 mRNA | CTD | PMID:19136453 and PMID:21427059 | valproic acid | multiple interactions | ISO | GPR160 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GPR160 mRNA | CTD | PMID:27188386 | valproic acid | increases expression | ISO | GPR160 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of GPR160 mRNA | CTD | PMID:23179753 more ... | valproic acid | affects expression | ISO | GPR160 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of GPR160 mRNA | CTD | PMID:25979313 | vinclozolin | increases expression | ISO | Gpr160 (Rattus norvegicus) | 6480464 | vinclozolin results in increased expression of GPR160 mRNA | CTD | PMID:23034163 | |